Mirogabalin for Central Neuropathic Pain After Spinal Cord Injury: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study in Asia

BACKGROUND AND OBJECTIVES: Patients with spinal cord injury (SCI) commonly experience central neuropathic pain (CNeP), which is challenging to treat. Mirogabalin is effective for peripheral neuropathic pain, but evidence for CNeP is lacking. METHODS: This randomized, double-blind, placebo-controlled...

Descripción completa

Detalles Bibliográficos
Autores principales: Ushida, Takahiro, Katayama, Yoichi, Hiasa, Yoichi, Nishihara, Makoto, Tajima, Fumihiro, Katoh, Shinsuke, Tanaka, Hirotaka, Maeda, Takeshi, Furusawa, Kazunari, Richardson, Mary, Kakehi, Yoshihiro, Kikumori, Kunika, Kuroha, Masanori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074464/
https://www.ncbi.nlm.nih.gov/pubmed/36517235
http://dx.doi.org/10.1212/WNL.0000000000201709

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074464/
https://www.ncbi.nlm.nih.gov/pubmed/36517235
http://dx.doi.org/10.1212/WNL.0000000000201709

Ejemplares similares